• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用未添加二甲基亚砜的分化人血清培养 Huh7.5-NTCP 细胞进行乙型肝炎病毒的体外感染。

In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide.

机构信息

Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, 6010 Katz Centre for Health Research, University of Alberta, Edmonton, AB T6G 2E1, Canada.

出版信息

Viruses. 2021 Jan 12;13(1):97. doi: 10.3390/v13010097.

DOI:10.3390/v13010097
PMID:33445753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7828204/
Abstract

An estimated two billion people worldwide have been infected with hepatitis B virus (HBV). Despite the high infectivity of HBV in vivo, a lack of easily infectable in vitro culture systems hinders studies of HBV. Overexpression of the sodium taurocholate co-transporting polypeptide (NTCP) bile acid transporter in hepatoma cells improved infection efficiency. We report here a hepatoma cell culture system that does not require dimethyl sulfoxide (DMSO) for HBV infection. We overexpressed NTCP in Huh7.5 cells and allowed these cells to differentiate in a medium supplemented with human serum (HS) instead of fetal bovine serum (FBS). We show that human serum culture enhanced HBV infection in Huh7.5-NTCP cells, e.g., in HS cultures, HBV pgRNA levels were increased by as much as 200-fold in comparison with FBS cultures and 19-fold in comparison with FBS+DMSO cultures. Human serum culture increased levels of hepatocyte differentiation markers, such as albumin secretion, in Huh7.5-NTCP cells to similar levels found in primary human hepatocytes. N-glycosylation of NTCP induced by culture in human serum may contribute to viral entry. Our study demonstrates an in vitro HBV infection of Huh7.5-NTCP cells without the use of potentially toxic DMSO.

摘要

据估计,全球有 20 亿人感染了乙型肝炎病毒 (HBV)。尽管 HBV 在体内具有很高的传染性,但缺乏易于体外培养的系统阻碍了对 HBV 的研究。在肝癌细胞中过表达牛磺胆酸钠共转运多肽 (NTCP) 胆汁酸转运蛋白可提高感染效率。我们在此报告一种不需要二甲亚砜 (DMSO) 即可进行 HBV 感染的肝癌细胞培养系统。我们在 Huh7.5 细胞中过表达了 NTCP,并允许这些细胞在补充有人类血清 (HS) 的培养基中分化,而不是胎牛血清 (FBS)。我们表明,人血清培养可增强 Huh7.5-NTCP 细胞中的 HBV 感染,例如,在 HS 培养物中,与 FBS 培养物相比,HBV pgRNA 水平增加了多达 200 倍,与 FBS+DMSO 培养物相比增加了 19 倍。人血清培养可增加 Huh7.5-NTCP 细胞中肝细胞分化标志物的水平,如白蛋白分泌,与原代人肝细胞中的水平相当。在人血清中培养诱导的 NTCP 的 N-糖基化可能有助于病毒进入。我们的研究证明了 Huh7.5-NTCP 细胞在没有使用潜在毒性的 DMSO 的情况下进行体外 HBV 感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/c46ddc2bf790/viruses-13-00097-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/54242b9f1c01/viruses-13-00097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/01702507c688/viruses-13-00097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/3327070f0d4b/viruses-13-00097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/5d689bc8f3cb/viruses-13-00097-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/ca4d8c527034/viruses-13-00097-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/519a3579e3bf/viruses-13-00097-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/c46ddc2bf790/viruses-13-00097-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/54242b9f1c01/viruses-13-00097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/01702507c688/viruses-13-00097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/3327070f0d4b/viruses-13-00097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/5d689bc8f3cb/viruses-13-00097-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/ca4d8c527034/viruses-13-00097-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/519a3579e3bf/viruses-13-00097-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673f/7828204/c46ddc2bf790/viruses-13-00097-g007.jpg

相似文献

1
In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide.使用未添加二甲基亚砜的分化人血清培养 Huh7.5-NTCP 细胞进行乙型肝炎病毒的体外感染。
Viruses. 2021 Jan 12;13(1):97. doi: 10.3390/v13010097.
2
Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.乙型肝炎病毒感染和复制的稳健人源和鼠源肝细胞培养模型。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01255-18. Print 2018 Dec 1.
3
Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.牛磺胆酸钠共转运多肽作为乙型肝炎病毒受体的独特特征
J Virol. 2016 Aug 26;90(18):8302-13. doi: 10.1128/JVI.01153-16. Print 2016 Sep 15.
4
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.乙型肝炎和丁型肝炎病毒利用牛磺胆酸钠共转运多肽进行种属特异性进入肝细胞。
Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.
5
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.利用过表达膜转运蛋白 NTCP 的 HepG2 细胞评价和鉴定乙型肝炎病毒进入抑制剂。
Biochem Biophys Res Commun. 2014 Jan 17;443(3):808-13. doi: 10.1016/j.bbrc.2013.12.052. Epub 2013 Dec 14.
6
Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.乙型肝炎和丁型肝炎病毒的病毒进入以及胆汁盐转运共用牛磺胆酸钠共转运多肽上的共同分子决定因素。
J Virol. 2014 Mar;88(6):3273-84. doi: 10.1128/JVI.03478-13. Epub 2014 Jan 3.
7
Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells.能够在分化良好、表达 hNTCP 的人肝癌衍生(Huh7)细胞中有效复制 HBV。
Virol Sin. 2017 Dec;32(6):465-475. doi: 10.1007/s12250-017-3983-x. Epub 2017 Sep 29.
8
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.环孢素衍生物可抑制乙型肝炎病毒进入,而不干扰钠-牛磺胆酸共转运多肽(NTCP)转运体活性。
J Hepatol. 2017 Apr;66(4):685-692. doi: 10.1016/j.jhep.2016.11.009. Epub 2016 Nov 25.
9
Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.乙肝病毒对HepaRG细胞、HepaRG-hNTCP细胞和原代人肝细胞的感染
Methods Mol Biol. 2017;1540:15-25. doi: 10.1007/978-1-4939-6700-1_2.
10
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.环孢素 A 通过非亲环素依赖性干扰 NTCP 受体抑制乙型肝炎和丁型肝炎病毒进入。
J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1.

引用本文的文献

1
The Evolution of Cell Culture Systems to Study Hepatitis B Virus Pathogenesis and Antiviral Susceptibility.用于研究乙型肝炎病毒发病机制和抗病毒敏感性的细胞培养系统的演变
Viruses. 2025 Jul 29;17(8):1057. doi: 10.3390/v17081057.
2
Loss of ADAR1 protein induces changes in small RNA landscape in hepatocytes.ADAR1 蛋白缺失导致肝细胞中小 RNA 景观发生变化。
RNA. 2024 Aug 16;30(9):1164-1183. doi: 10.1261/rna.080097.124.
3
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective.动物细胞系作为病毒疫苗生产中的表达平台:后新冠疫情视角

本文引用的文献

1
Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?先进疗法、疫苗接种和精准医学在慢性乙型肝炎病毒感染的治疗和管理中的应用;我们现在在哪里,我们将走向何方?
Viruses. 2020 Sep 7;12(9):998. doi: 10.3390/v12090998.
2
The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy.慢性乙型肝炎治疗的阴阳之道——何时开始,何时停止核苷(酸)类似物治疗。
Viruses. 2020 Aug 25;12(9):934. doi: 10.3390/v12090934.
3
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection.
ACS Omega. 2024 Apr 2;9(15):16904-16926. doi: 10.1021/acsomega.3c10484. eCollection 2024 Apr 16.
4
Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections.用于研究乙型肝炎和丁型肝炎病毒感染的细胞培养系统
Life (Basel). 2023 Jul 8;13(7):1527. doi: 10.3390/life13071527.
5
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis.HBx 与乙型肝炎病毒相关发病机制的相关性。
Int J Mol Sci. 2023 Mar 4;24(5):4964. doi: 10.3390/ijms24054964.
6
Long-term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration.通过逐步培养配置实现人肝细胞的长期细胞命运和功能维持。
FASEB J. 2023 Feb;37(2):e22750. doi: 10.1096/fj.202201292RR.
7
HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection.对乙型肝炎病毒感染表现出高易感性的HepG2-NTCP亚克隆
Viruses. 2022 Aug 17;14(8):1800. doi: 10.3390/v14081800.
8
Entry Inhibitors of Hepatitis B and D Viruses.乙型肝炎病毒和丁型肝炎病毒的进入抑制剂
Adv Exp Med Biol. 2022;1366:199-205. doi: 10.1007/978-981-16-8702-0_12.
基于 RNAi 的乙型肝炎病毒感染治疗进展。
Viruses. 2020 Aug 4;12(8):851. doi: 10.3390/v12080851.
4
Innovative HBV Animal Models Based on the Entry Receptor NTCP.基于乙肝病毒进入受体 NTCP 的创新型 HBV 动物模型。
Viruses. 2020 Jul 30;12(8):828. doi: 10.3390/v12080828.
5
Aptamer Binding Assay for the E Antigen of Hepatitis B Using Modified Aptamers with G-Quadruplex Structures.基于 G-四链体结构修饰的适体对乙型肝炎表面抗原的结合分析
Anal Chem. 2020 May 5;92(9):6495-6501. doi: 10.1021/acs.analchem.9b05740. Epub 2020 Apr 16.
6
Long-term functional maintenance of primary human hepatocytes in vitro.原代人肝细胞体外长期功能维持。
Science. 2019 Apr 26;364(6438):399-402. doi: 10.1126/science.aau7307.
7
DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro.DMSO 诱导体外人类细胞过程和表观遗传景观的剧烈变化。
Sci Rep. 2019 Mar 15;9(1):4641. doi: 10.1038/s41598-019-40660-0.
8
Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.用于研究乙型肝炎病毒感染和药物开发的细胞和动物模型。
Gastroenterology. 2019 Jan;156(2):338-354. doi: 10.1053/j.gastro.2018.06.093. Epub 2018 Sep 19.
9
Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.乙型肝炎病毒感染和复制的稳健人源和鼠源肝细胞培养模型。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01255-18. Print 2018 Dec 1.
10
T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.T5 外切核酸酶对乙型肝炎病毒复制中间体的水解作用允许通过 PCR 可靠地定量和快速检测共价闭合环状 DNA 的药物疗效。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01117-18. Print 2018 Dec 1.